Tagged with HR

Pharma Dr. Anna Maria Porrini, President of Boehringer Ingelheim Italy shares her vision for the company, how she intends to achieve it and where she sees opportunities for the company’s success in the market. Dr. Porrini, since we last spoke in 2009, Boehringer Ingelheim Italy has weathered the crisis and emerged…

pharma The president of the Institut Pasteur talks about how they must build on their differentiating factors, with a focus on interdisciplinary research, why they are not a French institute with international partnerships, but an international institute that is based in France and how if there was one aspect he would…

Pharma “Egypt will become the largest market for pharmaceuticals within the region in the next three years”; Ahsraf Elkhouly, Executive Director the Egyptian Society for Pharmaceutical Research (ESPR), highlights Egypt’s untapped potential and explains the challenges currently being overcome in Egypt’s pharmaceutical sector. What makes Egypt the ‘go to’ market in…

Pharma Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare system. He also describes AbbVie’s role in this industry collective, and also depicts the company’s developing foothold within the South…

Pharma Stem cell therapy holds the promise to treat diseases for which there are currently no or only limited therapeutic options. Christine Mummery, Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology at the Leiden University Medical Center, discusses how academia and industry can work together to…

pharma The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why South Africa acts as a springboard for many companies looking to develop their footprint in the region, making it the…

pharma Thomas Würdinger, winner of the 2014 Galenus prize, discusses his research team’s efforts to developing new treatment options and protocols for brain cancers, and the need for greater attention and investment in brain cancer treatment development, an area he identifies as the greatest unmet medical need in the field of…

Pharma The head of Aspen sterile operations and managing director of Aspen NDB, reveals how their facility in France acts as the main platform for the group´s sterile business, a market with tremendous potential at the world level; how the factory has a particularly strong international exposure, exporting 75 percent of…

pharma The CEO and founder of ModiQuest discusses how, with its unique, fully-integrated antibody generation and development platform, the company is developing antibodies for potentially groundbreaking therapies for the prevention and treatment of rheumatoid arthritis and growing its already well-established CRO arm serving clients from around the world. Could you introduce…

Algeria Arnaud de Rincquesen – Managing Partner, Deloitte: Companies are willing to come to Algeria. It’s an interesting market. What matters once again is to have a job market. The biggest issue for a company settling in Algeria is to find peo- ple with specialized skills and a good academic level.…

pharma Lourdes de Cárdenas, vice president of Stryker’s Latin American operations, explains how she has revamped the Puerto Rican facility to become a more efficient operation and their current vision to continually improve and exceed expectations as a critical supplier of disposables for the company. How do you find the Stryker…

Algeria